None listed
Conditions
Brief summary
During the COVID-19 pandemic there was a rapid move to telehealth use (either via phone or video) in the delivery of pregnancy care. There have been mixed findings from research conducted during the COVID-19 pandemic in Australia and elsewhere. One local study found the use of telehealth at Monash Health showed no compromise to pregnancy outcomes, however women didn’t receive telehealth for all of their pregnancy as some care was provided prior to the start of the COVID-19 pandemic. Another multi-centre cohort study including all public maternity services in metropolitan Melbourne found an increase in preterm stillbirths during lockdown periods and a decrease in medically required preterm births, which could be related to there being fewer episodes of in-person pregnancy care during lockdowns. This two-arm pilot randomised controlled trial (RCT) aims to develop and implement an agreed pregnancy care schedule that combines video-based telehealth care (referred to as telehealth hereafter) with face-to-face visits, and test it against a schedule of all face-to-face visits, with the ultimate aim of testing these in an adequately powered RCT. This study will be conducted at the Women’s and Mercy Hospital for Women. We will recruit 200 pregnant women who are obstetrically low-risk, with approximately 100 women randomised to receive all face-to-face pregnancy care, and 100 to receive combined telehealth and face-to-face care. Participants will complete a survey at recruitment and at two months post birth. Clinical data for each participant will be collected from their medical record. A second component of this pilot study is to evaluate obstetric and midwifery staff views and experiences of providing pregnancy care via telehealth. An online survey will be sent to all obstetric and midwifery staff to explore their views. Findings from this study will help to inform the development of a larger trial investigating the use of telehealth in providing pregnancy care.
Interventions
This study will have two arms – the intervention: combined video-based telehealth and face-to-face pregnancy care; and the control: all face-to-face pregnancy care. For each trial arm the schedule for pregnancy visits will follow the routine schedule for each study site, the location for the visit will change depending on which trial arm the participant is allocated. The following is draft of the expected schedule of visits for the intervention: Intervention: Combined video-based telehealth and face-to-face pregnancy care 20-22 weeks gestation: Midwife appointment telehealth: Midwife reviews and discusses patients’ morphology ultrasound, if occurs prior to this appointment, organises further ultrasounds if required, assesses maternal and fetal health and concerns via discussion (e.g., fetal movement, presence/occurrence of pain/bleeding etc.), answers questions and provides education and screening appropriate to gestation, individual needs, and hospital guidelines. Midwife reviews recent tests if occurred prior to this appointment and organises further testing/management if required. Midwife organises gestational diabetes testing and any other testing appropriate to risk factors/indication prior to next appointment. Midwife records recent blood pressure (either undertaken in community or at home) and acts upon if required. Duration 20 minutes 28 weeks gestation: Midwife appointment face-to-face: Midwife reviews and discusses patients’ morphology ultrasound if occurred post last appointment, assesses maternal and fetal health and concerns via discussion (e.g., fetal movement, presence/occurrence of pain/bleeding etc.), answers questions and provides education and screening appropriate to gestation, individual needs, and hospital guidelines. Midwife reviews recent tests/ultrasounds if occurred prior to this appointment and organises further testing/management if required. Midwife carries out symphysis-pubis fundal height measurement, abdominal palpation for fetal position, fetal heart rate auscultation and measures blood pressure and acts upon any abnormal findings. If the woman is a negative blood group, Anti-D is administered. Duration 20 minutes 31-32 weeks gestation: Midwife appointment telehealth: Midwife assesses maternal and fetal health and concerns via discussion (e.g., fetal movement, presence/occurrence of pain/bleeding etc.), answers questions and provides education and screening appropriate to gestation, individual needs, and hospital guidelines. Midwife reviews any recent tests/ultrasounds and organises further testing/management if required. Midwife records recent blood pressure (either undertaken in community or at home) and acts upon if required. Duration 20 minutes 34 weeks gestation: Midwife appointment telehealth*: Midwife assesses maternal and fetal health and concerns via discussion (e.g., fetal movement, presence/occurrence of pain/bleeding etc.), answers questions and provides education and screening appropriate to gestation, individual needs, and hospital guidelines. Midwife reviews any recent tests/ultrasounds and organises further testing/management if required. Midwife records recent blood pressure (either undertaken in community or at home) and acts upon if required. Duration 20 minutes 36 weeks gestation: Midwife appointment face-to-face: Midwife assesses maternal and fetal health and concerns via discussion (e.g., fetal movement, presence/occurrence of pain/bleeding etc.), answers questions and provides education and screening appropriate to gestation, individual needs, and hospital guidelines. Midwife reviews recent tests/ultrasounds if occurred prior to this appointment and organises further testing/management if required. Midwife carries out symphysis-pubis fundal height measurement, abdominal palpation for fetal position, fetal heart rate auscultation and measures blood pressure and acts upon any abnormal findings. If woman consents, midwife organises Group B Streptococcus testing. Duration 20 minutes. 38 weeks gestation: Midwife appointment telehealth: Midwife assesses maternal and fetal health and concerns via discussion (e.g., fetal movement, presence/occurrence of pain/bleeding etc.), answers questions and provides education and screening appropriate to gestation, individual needs, and hospital guidelines. Midwife reviews any recent tests/ultrasounds and organises further testing/management if required. Midwife records recent blood pressure (either undertaken in community or at home) and acts upon if required. Duration 20 minutes 40 weeks gestation: Midwife appointment face-to-face: Midwife assesses maternal and fetal health and concerns via discussion (e.g., fetal movement, presence/occurrence of pain/bleeding etc.), answers questions and provides education and screening appropriate to gestation, individual needs, and hospital guidelines. Midwife reviews recent tests/ultrasounds if occurred prior to this appointment and organises further testing/management if required. Midwife carries out symphysis-pubis fundal height measurement, abdominal palpation for fetal position, fetal heart rate auscultation and measures blood pressure and acts upon any abnormal findings. Duration 20 minutes. 41 weeks gestation: Midwife appointment face-to-face: Midwife assesses maternal and fetal health and concerns via discussion (e.g., fetal movement, presence/occurrence of pain/bleeding etc.), answers questions and provides education and screening appropriate to gestation, individual needs, and hospital guidelines. Midwife reviews recent tests/ultrasounds if occurred prior to this appointment and organises further testing/management if required. Midwife carries out symphysis-pubis fundal height measurement, abdominal palpation for fetal position, fetal heart rate auscultation and measures blood pressure and acts upon any abnormal findings. Midwife organises follow up for induction of labour planning as per hospital guidelines. Duration 20 minutes. *Where the woman is a negative blood group, this appointment will be made face-to-face to accommodate anti-D administration As telehealth visits will be conducted via video, routine physically examinations such as fundal height (measurement to monitor growth of the fetus), abdominal palpation for fetal position, auscultation of the fetal heart and blood pressure measurement will not be able to be undertaken during the appointment. Potential alternative arrangements for conducting these physical examinations (e.g. measurement of blood pressure at pharmacy or GP prior to telehealth appointment) will be guided by the processes currently in place at each study site. Adherence to the intervention will be assessed by auditing all participants electronic medical record or hospital administration record (site dependent) to assess if appointment was conducted on the above schedule and location (e.g., telehealth/face-to-face) as planned.
Sponsors
Study design
Eligibility
Inclusion criteria
Women with a singleton pregnancy attending either study sites as a public patient, planning to have their baby at study site and assessed as low obstetric risk, less than 24 weeks’ gestation, and able to speak and understand English.
Exclusion criteria
Women will not be eligible if they meet any of the following: • Require specialist care for alcohol and drug issues • Are experiencing significant mental health issues • Are unable to provide informed consent • Do not have access to a suitable device (e.g. smart phone, computer, tablet) for video telehealth appointments If they want to have their pregnancy care with an external provider (e.g. GP shared care), as the majority of care is provided by the external provider, and therefore it will be difficult to ensure the allocated trial arm schedule is adhered to by the external provider.